Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.05
Delayed Data
As of Jan 20
 +0.24 / +4.13%
Today’s Change
4.76
Today|||52-Week Range
8.24
+1.68%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close5.81
Today’s open5.90
Day’s range5.89 - 6.05
Volume1,756
Average volume (3 months)13,094
Market cap$29.3M
Dividend yield--
Data as of 3:01pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio30.2
Price/Sales2.32
Price/Book1.74

Competitors

 Today’s
change
Today’s
% change
BPMXBiopharmx Corp+0.00+0.68%
CANFCan Fite Biopharma L...-0.01-0.48%
CLBSCaladrius Bioscience...+0.03+0.84%
VTGNVistaGen Therapeutic...+0.00+0.00%
Data as of 4:02pm ET, 01/20/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts


Search for Jobs